Johnson & Johnson has set the date for delivery of its US vaccine to Europe from April 19.
And this vaccine became in mid-March the fourth that gets the green light from the European Medicines Agency after Pfizer / Biontec, Moderna and AstraZeneca, and it is currently used in the United States and South Africa only, but it has obtained a license in Canada as well.
To allow production to increase and meet demand, Johnson & Johnson has in recent months entered into contracts with laboratories and contracted with subcontractors in Europe.
The active ingredient that gives the vaccine its effectiveness will come from the Johnson & Johnson site in Leiden, in the Netherlands.
The European Union has requested to obtain 200 million doses from the US laboratory, with the possibility of ordering an additional 200 million. It will receive about 55 million doses in the second quarter, which was announced by Ursula von der Leyen, President of the European Commission, in mid-March. The laboratory has not revealed a specific timeline for delivering these doses.
Unlike other vaccines approved by the World Health Organization, the vaccine is given in a single dose instead of two and can be stored in a normal refrigerator.
Follow our latest local and sports news, and the latest political and economic developments via Google news
Source site www.emaratalyoum.com